Cite
1084-179 Ezetimibe/Simvastatin therapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol.
MLA
Bays, Harold E., et al. “1084-179 Ezetimibe/Simvastatin Therapy Is More Effective than Simvastatin Alone at Reducing Remnant-like Particle Cholesterol.” Journal of the American College of Cardiology (JACC), vol. 43, Mar. 2004, p. A481. EBSCOhost, https://doi.org/10.1016/S0735-1097(04)92036-0.
APA
Bays, H. E., Ose, L., Fraser, N., Quinto, K. L., Reyes, R., Sapre, A., Tribble, D., & Donahue, S. R. (2004). 1084-179 Ezetimibe/Simvastatin therapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol. Journal of the American College of Cardiology (JACC), 43, A481. https://doi.org/10.1016/S0735-1097(04)92036-0
Chicago
Bays, Harold E, Leiv Ose, Neil Fraser, Katherine L Quinto, Robert Reyes, Aditi Sapre, Diane Tribble, and Stephen R Donahue. 2004. “1084-179 Ezetimibe/Simvastatin Therapy Is More Effective than Simvastatin Alone at Reducing Remnant-like Particle Cholesterol.” Journal of the American College of Cardiology (JACC) 43 (March): A481. doi:10.1016/S0735-1097(04)92036-0.